Annual SGA
$7.96 M
+$511.80 K+6.87%
December 31, 2022
Summary
- As of February 20, 2025, NAVB annual SGA is $7.96 million, with the most recent change of +$511.80 thousand (+6.87%) on December 31, 2022.
- During the last 3 years, NAVB annual SGA has risen by +$1.69 million (+26.87%).
- NAVB annual SGA is now -48.77% below its all-time high of $15.54 million, reached on December 31, 2014.
Performance
NAVB SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$1.30 M
-$19.70 K-1.49%
September 30, 2023
Summary
- As of February 20, 2025, NAVB quarterly SGA is $1.30 million, with the most recent change of -$19.70 thousand (-1.49%) on September 30, 2023.
- Over the past year, NAVB quarterly SGA has dropped by -$19.70 thousand (-1.49%).
- NAVB quarterly SGA is now -76.31% below its all-time high of $5.49 million, reached on March 31, 2015.
Performance
NAVB Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.55 B
-$1.39 M-0.09%
September 30, 2023
Summary
- As of February 20, 2025, NAVB TTM SGA is -$1.55 billion, with the most recent change of -$1.39 million (-0.09%) on September 30, 2023.
- Over the past year, NAVB TTM SGA has dropped by -$1.55 billion (-21084.28%).
- NAVB TTM SGA is now -11800.35% below its all-time high of -$13.00 million.
Performance
NAVB TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
NAVB Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.9% | -1.5% | -10000.0% |
| 3 y3 years | +26.9% | -1.5% | -10000.0% |
| 5 y5 years | -28.7% | -1.5% | -10000.0% |
NAVB Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +6.9% | -64.2% | +12.7% | -5.6% | at low |
| 5 y | 5-year | at high | +26.9% | -64.2% | +12.7% | -12.6% | at low |
| alltime | all time | -48.8% | +246.2% | -76.3% | +137.2% | <-9999.0% | +0.9% |
Navidea Biopharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $1.30 M(-1.5%) | $5.04 M(-31.7%) |
| Jun 2023 | - | $1.32 M(+14.4%) | $7.37 M(+0.9%) |
| Mar 2023 | - | $1.15 M(-8.2%) | $7.31 M(-8.2%) |
| Dec 2022 | $7.96 M(+6.9%) | $1.26 M(-65.4%) | $7.96 M(-11.7%) |
| Sep 2022 | - | $3.64 M(+189.7%) | $9.02 M(+31.6%) |
| Jun 2022 | - | $1.26 M(-30.6%) | $6.85 M(-2.5%) |
| Mar 2022 | - | $1.81 M(-21.9%) | $7.03 M(-5.6%) |
| Dec 2021 | $7.45 M(+11.3%) | $2.32 M(+57.7%) | $7.45 M(+8.3%) |
| Sep 2021 | - | $1.47 M(+2.6%) | $6.88 M(-4.4%) |
| Jun 2021 | - | $1.43 M(-35.8%) | $7.20 M(+1.5%) |
| Mar 2021 | - | $2.23 M(+27.6%) | $7.10 M(+6.0%) |
| Dec 2020 | $6.70 M(+6.7%) | $1.75 M(-2.2%) | $6.70 M(+9.5%) |
| Sep 2020 | - | $1.79 M(+34.5%) | $6.11 M(+4.6%) |
| Jun 2020 | - | $1.33 M(-27.3%) | $5.84 M(-8.3%) |
| Mar 2020 | - | $1.83 M(+56.8%) | $6.37 M(+1.6%) |
| Dec 2019 | $6.28 M(-18.5%) | $1.17 M(-23.3%) | $6.28 M(-4.2%) |
| Sep 2019 | - | $1.52 M(-18.4%) | $6.55 M(-15.1%) |
| Jun 2019 | - | $1.86 M(+7.7%) | $7.72 M(+0.9%) |
| Mar 2019 | - | $1.73 M(+19.7%) | $7.65 M(-0.6%) |
| Dec 2018 | $7.70 M(-31.1%) | $1.44 M(-46.3%) | $7.70 M(-8.5%) |
| Sep 2018 | - | $2.69 M(+50.3%) | $8.42 M(+12.8%) |
| Jun 2018 | - | $1.79 M(+0.7%) | $7.46 M(-24.8%) |
| Mar 2018 | - | $1.78 M(-17.9%) | $9.92 M(-11.2%) |
| Dec 2017 | $11.17 M(+41.0%) | $2.16 M(+24.7%) | $11.17 M(+0.7%) |
| Sep 2017 | - | $1.73 M(-59.2%) | $11.09 M(-0.7%) |
| Jun 2017 | - | $4.25 M(+40.6%) | $11.17 M(+34.4%) |
| Mar 2017 | - | $3.02 M(+44.8%) | $8.31 M(+4.9%) |
| Dec 2016 | $7.92 M(-27.3%) | $2.09 M(+15.2%) | $7.92 M(+144.8%) |
| Sep 2016 | - | $1.81 M(+30.5%) | $3.24 M(-39.7%) |
| Jun 2016 | - | $1.39 M(-47.3%) | $5.37 M(-33.2%) |
| Mar 2016 | - | $2.63 M(-201.4%) | $8.03 M(-26.3%) |
| Dec 2015 | $10.89 M(-29.9%) | -$2.60 M(-165.9%) | $10.89 M(-38.0%) |
| Sep 2015 | - | $3.94 M(-2.6%) | $17.56 M(+8.0%) |
| Jun 2015 | - | $4.05 M(-26.3%) | $16.27 M(-5.0%) |
| Mar 2015 | - | $5.49 M(+34.8%) | $17.13 M(+10.2%) |
| Dec 2014 | $15.54 M(+0.1%) | $4.08 M(+54.0%) | $15.54 M(+0.4%) |
| Sep 2014 | - | $2.65 M(-46.1%) | $15.49 M(-7.9%) |
| Jun 2014 | - | $4.91 M(+25.5%) | $16.81 M(+4.6%) |
| Mar 2014 | - | $3.91 M(-2.7%) | $16.07 M(+3.5%) |
| Dec 2013 | $15.53 M(+38.9%) | $4.02 M(+1.2%) | $15.53 M(+9.4%) |
| Sep 2013 | - | $3.97 M(-4.8%) | $14.20 M(+7.8%) |
| Jun 2013 | - | $4.17 M(+23.9%) | $13.17 M(+10.0%) |
| Mar 2013 | - | $3.36 M(+25.1%) | $11.97 M(+7.1%) |
| Dec 2012 | $11.18 M(+17.1%) | $2.69 M(-8.6%) | $11.18 M(+6.1%) |
| Sep 2012 | - | $2.94 M(-1.0%) | $10.54 M(+0.7%) |
| Jun 2012 | - | $2.97 M(+15.4%) | $10.46 M(+13.5%) |
| Mar 2012 | - | $2.57 M(+25.7%) | $9.22 M(-3.4%) |
| Dec 2011 | $9.55 M(+119.3%) | $2.05 M(-28.6%) | $9.55 M(+10.8%) |
| Sep 2011 | - | $2.87 M(+66.2%) | $8.62 M(+22.5%) |
| Jun 2011 | - | $1.73 M(-40.5%) | $7.04 M(+13.0%) |
| Mar 2011 | - | $2.90 M(+159.1%) | $6.23 M(+39.8%) |
| Dec 2010 | $4.35 M(+34.3%) | $1.12 M(-13.0%) | $4.45 M(+7.1%) |
| Sep 2010 | - | $1.29 M(+40.2%) | $4.16 M(+13.9%) |
| Jun 2010 | - | $918.30 K(-18.6%) | $3.65 M(+3.3%) |
| Mar 2010 | - | $1.13 M(+37.1%) | $3.53 M(+9.0%) |
| Dec 2009 | $3.24 M(+9.3%) | $822.70 K(+5.7%) | $3.24 M(+16.1%) |
| Sep 2009 | - | $778.70 K(-2.9%) | $2.79 M(-1.2%) |
| Jun 2009 | - | $801.60 K(-4.3%) | $2.83 M(-3.5%) |
| Mar 2009 | - | $837.30 K(+124.3%) | $2.93 M(-1.3%) |
| Dec 2008 | $2.97 M | $373.30 K(-54.1%) | $2.97 M(-10.3%) |
| Sep 2008 | - | $812.80 K(-10.1%) | $3.31 M(+3.9%) |
| Jun 2008 | - | $903.90 K(+3.3%) | $3.18 M(+8.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | $875.40 K(+22.6%) | $2.93 M(+3.3%) |
| Dec 2007 | $2.84 M(-7.8%) | $714.30 K(+3.5%) | $2.84 M(-3.5%) |
| Sep 2007 | - | $690.20 K(+6.1%) | $2.94 M(+1.3%) |
| Jun 2007 | - | $650.30 K(-16.9%) | $2.90 M(-3.4%) |
| Mar 2007 | - | $782.60 K(-4.4%) | $3.01 M(-2.3%) |
| Dec 2006 | $3.08 M(-2.5%) | $818.70 K(+25.7%) | $3.08 M(+0.5%) |
| Sep 2006 | - | $651.40 K(-13.6%) | $3.06 M(-1.2%) |
| Jun 2006 | - | $753.80 K(-11.6%) | $3.10 M(-2.3%) |
| Mar 2006 | - | $852.50 K(+6.2%) | $3.17 M(+0.5%) |
| Dec 2005 | $3.16 M(+0.1%) | $802.70 K(+16.5%) | $3.16 M(+0.4%) |
| Sep 2005 | - | $689.00 K(-16.8%) | $3.14 M(-0.2%) |
| Jun 2005 | - | $827.80 K(-1.0%) | $3.15 M(-0.8%) |
| Mar 2005 | - | $836.10 K(+5.7%) | $3.18 M(+0.7%) |
| Dec 2004 | $3.15 M(+1.6%) | $791.10 K(+13.8%) | $3.15 M(-2.5%) |
| Sep 2004 | - | $695.40 K(-18.5%) | $3.23 M(-1.8%) |
| Jun 2004 | - | $853.10 K(+4.9%) | $3.29 M(+4.2%) |
| Mar 2004 | - | $813.40 K(-6.7%) | $3.16 M(+1.9%) |
| Dec 2003 | $3.10 M(-5.0%) | $871.80 K(+15.5%) | $3.10 M(+1.6%) |
| Sep 2003 | - | $755.10 K(+4.7%) | $3.05 M(-2.2%) |
| Jun 2003 | - | $721.50 K(-4.3%) | $3.12 M(-0.8%) |
| Mar 2003 | - | $754.10 K(-8.4%) | $3.15 M(-3.0%) |
| Dec 2002 | $3.27 M(+40.8%) | $823.40 K(-0.0%) | $3.24 M(+6.7%) |
| Sep 2002 | - | $823.60 K(+10.5%) | $3.04 M(+10.3%) |
| Jun 2002 | - | $745.60 K(-12.3%) | $2.75 M(+5.9%) |
| Mar 2002 | - | $850.60 K(+37.5%) | $2.60 M(+12.1%) |
| Dec 2001 | $2.32 M(-21.6%) | $618.70 K(+14.8%) | $2.32 M(-12.9%) |
| Sep 2001 | - | $538.90 K(-9.0%) | $2.66 M(-2.2%) |
| Jun 2001 | - | $592.50 K(+3.9%) | $2.72 M(-1.0%) |
| Mar 2001 | - | $570.30 K(-40.6%) | $2.75 M(-7.1%) |
| Dec 2000 | $2.96 M(-63.9%) | $960.90 K(+60.2%) | $2.96 M(+48.1%) |
| Sep 2000 | - | $599.70 K(-3.4%) | $2.00 M(+42.8%) |
| Jun 2000 | - | $620.60 K(-20.4%) | $1.40 M(-47.8%) |
| Mar 2000 | - | $779.20 K(-59.0%) | $2.68 M(-73.4%) |
| Dec 1999 | $8.21 M(-27.7%) | - | - |
| Jun 1999 | - | $1.90 M(-13.6%) | $10.06 M(-4.7%) |
| Mar 1999 | - | $2.20 M(-30.3%) | $10.56 M(-8.7%) |
| Dec 1998 | $11.36 M(+1.8%) | $3.16 M(+12.7%) | $11.56 M(-0.0%) |
| Sep 1998 | - | $2.80 M(+16.7%) | $11.56 M(+2.7%) |
| Jun 1998 | - | $2.40 M(-25.0%) | $11.26 M(-4.3%) |
| Mar 1998 | - | $3.20 M(+1.3%) | $11.76 M(+6.3%) |
| Dec 1997 | $11.16 M(+43.1%) | $3.16 M(+26.4%) | $11.06 M(-0.4%) |
| Sep 1997 | - | $2.50 M(-13.8%) | $11.10 M(+2.8%) |
| Jun 1997 | - | $2.90 M(+16.0%) | $10.80 M(+14.9%) |
| Mar 1997 | - | $2.50 M(-21.9%) | $9.40 M(+14.6%) |
| Dec 1996 | $7.80 M(+116.7%) | $3.20 M(+45.5%) | $8.20 M(+34.4%) |
| Sep 1996 | - | $2.20 M(+46.7%) | $6.10 M(+24.5%) |
| Jun 1996 | - | $1.50 M(+15.4%) | $4.90 M(+11.4%) |
| Mar 1996 | - | $1.30 M(+18.2%) | $4.40 M(+10.0%) |
| Dec 1995 | $3.60 M(-70.0%) | $1.10 M(+10.0%) | $4.00 M(-45.2%) |
| Sep 1995 | - | $1.00 M(0.0%) | $7.30 M(-20.7%) |
| Jun 1995 | - | $1.00 M(+11.1%) | $9.20 M(+3.4%) |
| Mar 1995 | - | $900.00 K(-79.5%) | $8.90 M(0.0%) |
| Dec 1994 | $12.00 M(+421.7%) | $4.40 M(+51.7%) | $8.90 M(+790.0%) |
| Sep 1994 | - | $2.90 M(+314.3%) | $1.00 M(+150.0%) |
| Jun 1994 | - | $700.00 K(-22.2%) | $400.00 K(-77.8%) |
| Mar 1994 | - | $900.00 K(-125.7%) | $1.80 M(-21.7%) |
| Dec 1993 | $2.30 M(-20.7%) | -$3.50 M(-252.2%) | $2.30 M(-66.2%) |
| Sep 1993 | - | $2.30 M(+9.5%) | $6.80 M(+25.9%) |
| Jun 1993 | - | $2.10 M(+50.0%) | $5.40 M(+63.6%) |
| Mar 1993 | - | $1.40 M(+40.0%) | $3.30 M(+73.7%) |
| Dec 1992 | $2.90 M | $1.00 M(+11.1%) | $1.90 M(+111.1%) |
| Sep 1992 | - | $900.00 K | $900.00 K |
FAQ
- What is Navidea Biopharmaceuticals annual SGA?
- What is the all time high annual SGA for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals annual SGA year-on-year change?
- What is Navidea Biopharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals quarterly SGA year-on-year change?
- What is Navidea Biopharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals TTM SGA year-on-year change?
What is Navidea Biopharmaceuticals annual SGA?
The current annual SGA of NAVB is $7.96 M
What is the all time high annual SGA for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high annual SGA is $15.54 M
What is Navidea Biopharmaceuticals annual SGA year-on-year change?
Over the past year, NAVB annual SGA has changed by +$511.80 K (+6.87%)
What is Navidea Biopharmaceuticals quarterly SGA?
The current quarterly SGA of NAVB is $1.30 M
What is the all time high quarterly SGA for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high quarterly SGA is $5.49 M
What is Navidea Biopharmaceuticals quarterly SGA year-on-year change?
Over the past year, NAVB quarterly SGA has changed by -$19.70 K (-1.49%)
What is Navidea Biopharmaceuticals TTM SGA?
The current TTM SGA of NAVB is -$1.55 B
What is the all time high TTM SGA for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high TTM SGA is -$13.00 M
What is Navidea Biopharmaceuticals TTM SGA year-on-year change?
Over the past year, NAVB TTM SGA has changed by -$1.55 B (-21084.28%)